Miracle Mile Advisors’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,000
Closed -$69K 311
2019
Q3
$69K Hold
5,000
﹤0.01% 274
2019
Q2
$53K Hold
5,000
﹤0.01% 256
2019
Q1
$53K Hold
5,000
﹤0.01% 264
2018
Q4
$41K Hold
5,000
﹤0.01% 143
2018
Q3
$82K Hold
5,000
0.01% 169
2018
Q2
$55K Hold
5,000
0.01% 160
2018
Q1
$58K Hold
5,000
0.01% 151
2017
Q4
$58K Hold
5,000
0.01% 105
2017
Q3
$55K Hold
5,000
0.01% 77
2017
Q2
$80K Hold
5,000
0.01% 72
2017
Q1
$90K Hold
5,000
0.02% 81
2016
Q4
$54K Buy
+5,000
New +$46.5K 0.01% 85
2016
Q3
Sell
-5,000
Closed -$41K 92
2016
Q2
$41K Buy
+5,000
New +$71.8K 0.01% 57

Other funds holding MESO

Miracle Mile Advisors's MESO Position: Q4 2019 in Review

Miracle Mile Advisors sold out of Mesoblast (MESO) in Q4 2019, closing a stake of 5,000 shares — an estimated $69K sold.

Miracle Mile Advisors first reported a position in MESO in Q2 2016 and held it in 13 quarters. The position peaked at $90K in Q1 2017. 28 funds tracked by Wall St. Rank hold MESO as of Q4 2019.

  • Miracle Mile Advisors reported no remaining Mesoblast position as of Q4 2019 after selling out during the quarter.
  • Miracle Mile Advisors sold 5,000 Mesoblast shares in Q4 2019, an estimated $69K.
  • Miracle Mile Advisors first reported a position in Mesoblast in Q2 2016 and held it in 13 quarters.
  • Miracle Mile Advisors's Mesoblast position peaked at $90K in Q1 2017.
  • 28 funds tracked by Wall St. Rank held Mesoblast as of Q4 2019.

Based on Miracle Mile Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.